JA
GILD icon

JLB & Associates’s Gilead Sciences GILD Stock Holding History

JLB & Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-9,411
Closed -$841K – 74
2019
Q2 		$841K Buy
9,411
+755
+9% +$49.7K 0.17% 58
2019
Q1 		$709K Buy
8,656
+863
+11% +$57.4K 0.15% 58
2018
Q4 		$580K Buy
7,793
+5,033
+182% +$352K 0.14% 60
2018
Q3 		$239K Sell
2,760
-11,822
-81% -$893K 0.05% 67
2018
Q2 		$1.06M Sell
14,582
-106,611
-88% -$7.53M 0.23% 55
2018
Q1 		$9.14M Buy
121,193
+1,517
+1% +$121K 1.97% 28
2017
Q4 		$8.57M Buy
119,676
+7,663
+7% +$582K 1.86% 28
2017
Q3 		$9.07M Sell
112,013
-1,984
-2% -$152K 2.22% 22
2017
Q2 		$8.07M Buy
+113,997
New +$7.59M 2.05% 25
2016
Q4 		$8.94M Buy
124,816
+651
+0.5% +$48.4K 2.42% 18
2016
Q3 		$9.82M Buy
124,165
+6,842
+6% +$556K 2.71% 10
2016
Q2 		$9.79M Sell
117,323
-7,169
-6% -$636K 2.77% 6
2016
Q1 		$8.28M Buy
124,492
+14,257
+13% +$1.29M 2.11% 22
2015
Q4 		$11.2M Buy
110,235
+83
+0.1% +$8.64K 3.45% 2
2015
Q3 		$10.8M Buy
110,152
+222
+0.2% +$24.7K 3.49% 2
2015
Q2 		$12.9M Buy
109,930
+2,105
+2% +$230K 3.99% 1
2015
Q1 		$10.6M Buy
107,825
+2,913
+3% +$296K 3.31% 3
2014
Q4 		$9.89M Sell
104,912
-5,558
-5% -$575K 3.28% 3
2014
Q3 		$11.8M Sell
110,470
-7,314
-6% -$716K 4.22% 1
2014
Q2 		$9.77M Sell
117,784
-6,673
-5% -$519K 3.55% 1
2014
Q1 		$8.82M Sell
124,457
-8,534
-6% -$669K 3.29% 3
2013
Q4 		$9.99M Sell
132,991
-5,741
-4% -$400K 3.8% 2
2013
Q3 		$8.72M Sell
138,732
-9,421
-6% -$563K 3.68% 1
2013
Q2 		$7.59M Buy
+148,153
New +$7.72M 3.46% 2

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JLB & Associates's GILD Position: Q3 2019 in Review

JLB & Associates sold out of Gilead Sciences (GILD) in Q3 2019, closing a stake of 9,411 shares — an estimated $841K sold.

JLB & Associates first reported a position in GILD in Q2 2013 and held it in 24 quarters. The position peaked at $12.9M in Q2 2015. 1,464 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

  • JLB & Associates reported no remaining Gilead Sciences position as of Q3 2019 after selling out during the quarter.
  • JLB & Associates sold 9,411 Gilead Sciences shares in Q3 2019, an estimated $841K.
  • JLB & Associates first reported a position in Gilead Sciences in Q2 2013 and held it in 24 quarters.
  • JLB & Associates's Gilead Sciences position peaked at $12.9M in Q2 2015.
  • 1,464 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on JLB & Associates's 13F filing for Q3 2019, filed 29 Oct 2019.